Works by Patel, Bhumika

Results: 56
    1

    Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocol.

    Published in:
    PLoS ONE, 2025, v. 20, n. 7, p. 1, doi. 10.1371/journal.pone.0325149
    By:
    • Brito-Mutunayagam, Sanjita;
    • Hamilton, David O.;
    • Mitsi, Elena;
    • Solórzano, Carla;
    • Li, Grace;
    • Rocha De Macedo, Bruno;
    • Elterish, Filora;
    • Liu, Xinxue;
    • Tanha, Kiarash;
    • White, Rachel;
    • Hyder-Wright, Angela;
    • Patel, Bhumika;
    • Urban, Britta C.;
    • Whelan, Conor;
    • Trari Belhadef, Hanane;
    • Robinson, Hannah;
    • Plested, Emma;
    • Thompson, Amber;
    • Lahuerta, Maria;
    • Kanevsky, Isis
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review.

    Published in:
    Innovations in Clinical Neuroscience, 2024, v. 21, n. 7-9, p. 27
    By:
    • IsHak, Waguih William;
    • Meyer, Ashley;
    • Freire, Luiza;
    • Totlani, Jayant;
    • Murphy, Nathalie;
    • Renteria, Sabrina;
    • Salem, Mohamed;
    • Chang, Tiffany;
    • Abdelsalam, Rasha;
    • Khan, Rida;
    • Chandy, Thomas;
    • Parrish, Thomas;
    • Hirsch, Drew;
    • Patel, Bhumika;
    • Steiner, Alexander J.;
    • Kim, Sarah;
    • Hedrick, Rebecca;
    • Pechnick, Robert N.;
    • Danovitch, Itai
    Publication type:
    Article
    13
    14

    Analysis of distinct SF3B1 hotspot mutations in relation to clinical phenotypes and response to therapy in myeloid neoplasia.

    Published in:
    2021
    By:
    • Adema, Vera;
    • Khouri, Jack;
    • Ni, Ying;
    • Rogers, Heesun J.;
    • Kerr, Cassandra M.;
    • Awada, Hassan;
    • Nagata, Yasunobu;
    • Kuzmanovic, Teodora;
    • Advani, Anjali S.;
    • Gerds, Aaron T.;
    • Mukherjee, Sudipto;
    • Nazha, Aziz;
    • Saunthararajah, Yogen;
    • Madanat, Yazan;
    • Patel, Bhumika J.;
    • Solé, Francesc;
    • Nawrocki, Steffan T.;
    • Carew, Jennifer S.;
    • Sekeres, Mikkael A.;
    • Maciejewski, Jaroslaw P.
    Publication type:
    Letter
    15
    16

    Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete response.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 2, p. 363, doi. 10.1080/10428194.2017.1344842
    By:
    • Saygin, Caner;
    • Papadantonakis, Nikolaos;
    • Cassaday, Ryan D.;
    • Liedtke, Michaela;
    • Fischer, Katrina;
    • Dunn, Tamara;
    • Patel, Bhumika J.;
    • Sobecks, Ronald;
    • Kalaycio, Matt;
    • Sekeres, Mikkael A.;
    • Mukherjee, Sudipto;
    • Gerds, Aaron T.;
    • Hamilton, Betty K.;
    • Carraway, Hetty E.;
    • Advani, Anjali S.
    Publication type:
    Article
    17

    Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL).

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 2, p. 416, doi. 10.1080/10428194.2017.1339880
    By:
    • Sanikommu, Srinivasa R.;
    • Clemente, Michael J.;
    • Chomczynski, Peter;
    • Afable II, Manuel G.;
    • Jerez, Andres;
    • Thota, Swapna;
    • Patel, Bhumika;
    • Hirsch, Cassandra;
    • Nazha, Aziz;
    • Desamito, John;
    • Lichtin, Alan;
    • Pohlman, Brad;
    • Sekeres, Mikkael A.;
    • Radivoyevitch, Tomas;
    • Maciejewski, Jaroslaw P.
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24

    Molecular patterns identify distinct subclasses of myeloid neoplasia.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38515-4
    By:
    • Kewan, Tariq;
    • Durmaz, Arda;
    • Bahaj, Waled;
    • Gurnari, Carmelo;
    • Terkawi, Laila;
    • Awada, Hussein;
    • Ogbue, Olisaemeka D.;
    • Ahmed, Ramsha;
    • Pagliuca, Simona;
    • Awada, Hassan;
    • Kutoba, Yasuo;
    • Mori, Minako;
    • Ponvilawan, Ben;
    • Al-Share, Bayan;
    • Patel, Bhumika J.;
    • Carraway, Hetty E.;
    • Scott, Jacob;
    • Balasubramanian, Suresh K.;
    • Bat, Taha;
    • Madanat, Yazan
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort.

    Published in:
    Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.649182
    By:
    • Westermann-Clark, Emma;
    • Meehan, Cristina Adelia;
    • Meyer, Anna K.;
    • Dasso, Joseph F.;
    • Amre, Devendra;
    • Ellison, Maryssa;
    • Patel, Bhumika;
    • Betensky, Marisol;
    • Hauk, Charles Isaac;
    • Mayer, Jennifer;
    • Metts, Jonathan;
    • Leiding, Jennifer W.;
    • Sriaroon, Panida;
    • Kumar, Ambuj;
    • Ayala, Irmel;
    • Walter, Jolan E.
    Publication type:
    Article
    37
    38
    39
    40

    Distinctive and common features of moderate aplastic anaemia.

    Published in:
    British Journal of Haematology, 2020, v. 189, n. 5, p. 967, doi. 10.1111/bjh.16460
    By:
    • Patel, Bhumika J.;
    • Barot, Shimoli V.;
    • Kuzmanovic, Teodora;
    • Kerr, Cassandra;
    • Przychodzen, Bartlomiej P.;
    • Thota, Swapna;
    • Lee, Sarah;
    • Patel, Saurabh;
    • Radivoyevitch, Tomas;
    • Lichtin, Alan;
    • Advani, Anjali;
    • Kalaycio, Matt;
    • Sekeres, Mikkael A.;
    • Carraway, Hetty E.;
    • Maciejewski, Jaroslaw P.
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48

    MDS-090: Phase II Study of the IDH2 Inhibitor Enasidenib in Patients with High-Risk IDH2-Mutated Myelodysplastic Syndromes (MDS).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S339, doi. 10.1016/S2152-2650(21)01791-2
    By:
    • Venugopal, Sangeetha;
    • DiNardo, Courtney D.;
    • Takahashi, Koichi;
    • Konopleva, Marina;
    • Loghavi, Sanam;
    • Borthakur, Gautam;
    • DeZern, Amy;
    • Masarova, Lucia;
    • Daver, Naval;
    • Short, Nicholas J.;
    • Alvarado, Yesid;
    • Ravandi, Farhad;
    • Montalban-Bravo, Guillermo;
    • Sasaki, Koji;
    • Delumpa, Ricardo;
    • Sekeres, Mikkael A.;
    • Patel, Bhumika;
    • Roboz, Gail J.;
    • Kantarjian, Hagop M.;
    • Garcia-Manero, Guillermo
    Publication type:
    Article
    49

    Poster: MDS-090: Phase II Study of the IDH2 Inhibitor Enasidenib in Patients with High-Risk IDH2-Mutated Myelodysplastic Syndromes (MDS).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S226, doi. 10.1016/S2152-2650(21)01427-0
    By:
    • Venugopal, Sangeetha;
    • DiNardo, Courtney D.;
    • Takahashi, Koichi;
    • Konopleva, Marina;
    • Loghavi, Sanam;
    • Borthakur, Gautam;
    • DeZern, Amy;
    • Masarova, Lucia;
    • Daver, Naval;
    • Short, Nicholas J.;
    • Alvarado, Yesid;
    • Ravandi, Farhad;
    • Montalban-Bravo, Guillermo;
    • Sasaki, Koji;
    • Delumpa, Ricardo;
    • Sekeres, Mikkael A.;
    • Patel, Bhumika;
    • Roboz, Gail J.;
    • Kantarjian, Hagop M.;
    • Garcia-Manero, Guillermo
    Publication type:
    Article
    50